Related Experiment Videos
[Function of oncogenes in neuroepithelial tumors]
1Neurologische Universitätsklinik, Göttingen.
Fortschritte Der Neurologie-Psychiatrie
|April 1, 1992
Summary
Protooncogenes can mutate into oncogenes, driving nervous system tumor development. Research highlights specific oncogene amplifications (N-myc, c-erbB) and expressions (c-sis) linked to poorer prognoses and malignancy in neuroepithelial tumors.
Area of Science:
- Molecular biology
- Oncology
- Genetics
Context:
- Protooncogenes are normal human genes that can mutate into oncogenes.
- Oncogenes play a role in the development of nervous system tumors.
- Recombinant DNA techniques are used to study oncogene loci.
Purpose:
- To survey current research on oncogene loci in neuroepithelial tumors.
- To investigate the association between specific oncogene amplifications/expressions and tumor characteristics.
Summary:
- Amplification of the N-myc oncogene in neuroblastomas correlates with a poorer prognosis.
- Amplification of the c-erbB oncogene, similar to the epidermal growth factor receptor gene, is found in malignant neuroepithelial tumors.
- Enhanced expression of the c-sis oncogene, coding for platelet-derived growth factor, is observed in 85% of malignant gliomas.
- Other oncogenes may also influence neuroepithelial tumor development, based on preliminary studies.
Impact:
- Provides insights into the molecular mechanisms of neuroepithelial tumor development.
- Identifies potential prognostic markers (e.g., N-myc amplification) for neuroblastomas.
- Highlights the role of specific oncogenes (c-erbB, c-sis) in malignant neuroepithelial neoplasias.
- Suggests avenues for further research into the role of various oncogenes in these tumors.